Glaukos up after FDA accepts marketing application for eye implant

Glaukos

08/05/2023 16:59

** Medtech firm Glaukos Corp shares  GKOS.N  up 3.4% at
$56.3 
    ** Glaukos Corp late on Friday said U.S. health regulator 
accepted marketing application of co's drug delivering eye
implant, iDose TR 
    ** FDA is set to make decision on marketing application for
eye device by Dec. 22, 2023 - GKOS
    ** Application is based on data from two late-stage studies
that achieved pre-specified efficacy and safety goals 
    ** Including session gains, stock up ~29% YTD

 (Reporting by Khushi Mandowara in Bengaluru)
 ((Khushi.Mandowara@thomsonreuters.com;))